Recall: D-1815-2015

Class II - Potentially Harmful

Class IIClassification
2015-08-25Initiated
OngoingStatus
Hospira, Inc.Firm

Product

1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservative Free, Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-4279-02

Reason

Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.